Houghton Adam sold 700 Upstream Bio shares at $5.49 per share on 2026-09-16, using SEC transaction code S. The sale left Houghton Adam with 22,901 shares, while the disclosed transaction represented about 3.0% of the prior holding, quantifying the change for investors tracking insider positions.
Key Highlights
- Houghton Adam reported a share sale involving Upstream Bio, Inc.
- The filing reports the sale at $5.49 per share.
- Houghton Adam held 22,901 Upstream Bio shares after the transaction.
Houghton Adam sold shares of Upstream Bio, Inc. (NASDAQ: UPB) at $5.49 per share and afterward owned 22,901 shares. The transaction represented about 3.0% of Houghton Adam’s prior share holding in Upstream Bio.
$5.49 Per-Share Sale
The remaining Upstream Bio position was 22,901 shares after the sale. The figure applies to Houghton Adam’s ownership following the transaction, rather than to the shares sold.
Sale Represented 3.0% of Prior Holding
The disclosed ownership after the sale was 22,901 shares. Upstream Bio is the company connected to the transaction.
FAQs
Q: At what price did Houghton Adam sell Upstream Bio shares?
A: Houghton Adam sold Upstream Bio, Inc. shares at $5.49 per share.
Q: What percentage of Houghton Adam’s prior holding did the sale represent?
A: The Upstream Bio insider transaction represented about 3.0% of Houghton Adam’s prior share holding.
Q: How many Upstream Bio shares did Houghton Adam own afterward?
A: Houghton Adam owned 22,901 Upstream Bio shares after the transaction. Houghton Adam is identified as Chief Business Officer of Upstream Bio, Inc.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.